These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6029941)

  • 1. Metabolic fate of l-[14C] DOPA in cerebrospinal fluid and blood plasma of humans.
    Pletscher A; Bartholini G; Tissot R
    Brain Res; 1967 Feb; 4(1):106-9. PubMed ID: 6029941
    [No Abstract]   [Full Text] [Related]  

  • 2. On the origin of homovanillic acid in the cerebrospinal fluid.
    Bartholini G; Pletscher A; Tissot R
    Experientia; 1966 Sep; 22(9):609-10. PubMed ID: 5970609
    [No Abstract]   [Full Text] [Related]  

  • 3. Accumulation of 3H-homovanillic acid in rabbit brain and cerebrospinal fluid following intravenous 3H-L-dopa.
    Extein I; Roth RH; Bowers MB
    Biol Psychiatry; 1974 Oct; 9(2):161-70. PubMed ID: 4429746
    [No Abstract]   [Full Text] [Related]  

  • 4. The metabolism of L-3-O-methyldopa, a precursor of dopa in man.
    Kuruma I; Bartholini G; Tissot R; Pletscher A
    Clin Pharmacol Ther; 1971; 12(4):678-82. PubMed ID: 5567811
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-induced changes of extracerebral dopa metabolism in man.
    Tissot R; Bartholini G; Pletscher A
    Arch Neurol; 1969 Feb; 20(2):187-90. PubMed ID: 5767016
    [No Abstract]   [Full Text] [Related]  

  • 6. The fate of C14-dihydroxyphenylalanine (C14-dopa) in the whole mouse.
    Wurtman RJ; Chou C; Rose C
    J Pharmacol Exp Ther; 1970 Sep; 174(3):351-6. PubMed ID: 5456168
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain.
    Moir AT; Ashcroft GW; Crawford TB; Eccleston D; Guldberg HC
    Brain; 1970; 93(2):357-68. PubMed ID: 4912291
    [No Abstract]   [Full Text] [Related]  

  • 8. L-dopa and cerebrospinal fluid homovanillic acid in Parkinsonism.
    Weiner W; Harrison W; Klawans H
    Life Sci; 1969 Sep; 8(17):971-6. PubMed ID: 5808572
    [No Abstract]   [Full Text] [Related]  

  • 9. Brain capillaries as a source of homovanillic acid in cerebrospinal fluid.
    Bartholini G; Tissot R; Pletscher A
    Brain Res; 1971 Mar; 27(1):163-8. PubMed ID: 5554221
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and cerebrospinal fluid changes in parkinsonian patients treated with L-3,4-dihydroxyphenylalanine (L-dopa).
    Sharpless NS; Ericsson AD; McCann DS
    Neurology; 1971 May; 21(5):540-9. PubMed ID: 5104098
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of L-DOPA on S-adenosylmethionine levels and norepinephrine metabolism in rat brain.
    Wurtman RJ
    Adv Biochem Psychopharmacol; 1972; 6():241-6. PubMed ID: 5055596
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism of levodopa in patients with Parkinson's disease. Radioactive and fluorometric assays.
    Morgan JP; Bianchine JR; Spiegel HE; Rivera-Calimlim L; Hersey RM
    Arch Neurol; 1971 Jul; 25(1):39-44. PubMed ID: 5146410
    [No Abstract]   [Full Text] [Related]  

  • 13. Absorption, metabolism and distribution of (14C)-O-methyldopa and (14C)-L-dopa after oral administration to rats.
    Rivera-Calimlim L
    Br J Pharmacol; 1974 Feb; 50(2):259-63. PubMed ID: 4425764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylethylene glycol in Parkinsonism before and after treatment with L-dopa.
    Wilk S; Mones R
    J Neurochem; 1971 Sep; 18(9):1771-3. PubMed ID: 5571114
    [No Abstract]   [Full Text] [Related]  

  • 15. The rate of metabolism of dopamine, dihydroxyphenylacetic acid and methoxytyramine in rabbit brain in vitro.
    Rutledge CO; Jonason J
    Eur J Pharmacol; 1968 Oct; 4(3):264-9. PubMed ID: 5723421
    [No Abstract]   [Full Text] [Related]  

  • 16. [Parkinsonism and plasma metabolism of dihydroxyphenylalanine administered with an inhibitor of decarboxylase].
    Geissbühler F; Constantinidis J; Eisenring JJ; Krassoievitch M; Yanniotis G; Tissot R
    Clin Chim Acta; 1971 Jun; 33(1):111-5. PubMed ID: 5097993
    [No Abstract]   [Full Text] [Related]  

  • 17. Simultaneous measurement of DOPA and its primary metabolites in physiological fluids.
    Hare TA; Beasley BL; DeSimone SM; Vogel WH
    Biochem Med; 1974 Dec; 11(4):305-11. PubMed ID: 4429548
    [No Abstract]   [Full Text] [Related]  

  • 18. Some studies of the effects of chlorpromazine, reserpine and dihydroxyphenylalanine on the concentrations of homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in ventricular cerebrospinal fluid of the dog using the technique of serial sampling of the cerebrospinal fluid.
    Guldberg HC; Yates CM
    Br J Pharmacol Chemother; 1968 Jul; 33(3):457-71. PubMed ID: 5728318
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of 3,4-dihydroxyphenylalanine (DOPA) in plasma and cerebrospinal fluid by high performance liquid chromatography with electrochemical detection.
    Boomsma F; van der Hoorn FA; Man in 't Veld AJ; Schalekamp MA
    Clin Chim Acta; 1988 Nov; 178(1):59-69. PubMed ID: 3147824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous measurement of DOPA, DOPAC, and catecholamines in plasma by liquid chromatography with electrochemical detection.
    Goldstein DS; Stull R; Zimlichman R; Levinson PD; Smith H; Keiser HR
    Clin Chem; 1984 May; 30(5):815-6. PubMed ID: 6424968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.